Regulatory News In Brief
This article was originally published in The Gray Sheet
Executive Summary
FDA issues procedures governing reviewers' requests for additional pre-market data from sponsors. Agency extends comment period for its de novo and 510(k) modification draft guidances. More regulatory briefs.